Does LUMATEPERONE Cause Product dose omission issue? 62 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Product dose omission issue have been filed in association with LUMATEPERONE (CAPLYTA). This represents 1.3% of all adverse event reports for LUMATEPERONE.
62
Reports of Product dose omission issue with LUMATEPERONE
1.3%
of all LUMATEPERONE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission issue From LUMATEPERONE?
Of the 62 reports, 5 (8.1%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUMATEPERONE. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does LUMATEPERONE Cause?
Dizziness (558)
Nausea (401)
Headache (358)
Somnolence (304)
Off label use (280)
Drug ineffective (241)
Mania (211)
Sedation (208)
Feeling abnormal (206)
Anxiety (183)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LUMATEPERONE Alternatives Have Lower Product dose omission issue Risk?
LUMATEPERONE vs LUMIGAN
LUMATEPERONE vs LUPRON DEPOT
LUMATEPERONE vs LUPRON DEPOT-PED
LUMATEPERONE vs LURASIDONE
LUMATEPERONE vs LURBINECTEDIN